Hospital
Valley Citizens' Foundation for Health Care INC
Valley Citizens' Foundation for Health Care INC was paid $3.56M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 99284, emergency room visit (serious) — 30% of everything it billed.
33Billing provider infoVALLEY CITIZENS' FOUNDATION FOR HEALTH CARE INC
DEL NORTE, CO 81132
DEL NORTE, CO 81132
33aNPI1396783981assigned 06/03/2006
33bProvider typeCritical Access Hospital
28Total paid$3.56M
24GClaims85,851
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Colorado
Rank by total paid#4 of 26
Median peer was paid$111K
This provider vs. median32×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,498 | $276K | |
| 2019 | 9,233 | $301K | |
| 2020 | 11,617 | $363K | |
| 2021 | 15,188 | $559K | |
| 2022 | 16,214 | $792K | |
| 2023 | 16,574 | $768K | |
| 2024incomplete | 9,527 | $498K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 30% | 10,318 | 7,266 | $1.06M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 9,507 | 7,242 | $937K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 4,146 | 2,835 | $474K |
| 96361 | Intravenous infusion, hydration; each additional hour | 10% | 1,438 | 1,143 | $366K |
| 80053 | Comprehensive metabolic panel | 3.8% | 9,573 | 7,553 | $135K |
| 83605 | 3.6% | 6,931 | 5,129 | $128K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 2,128 | 1,716 | $102K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 974 | 832 | $61K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 395 | 355 | $38K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 402 | 295 | $37K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 414 | 237 | $30K |
| 84484 | <1% | 1,375 | 947 | $20K |
46 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 482 | $20K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 58 | $19K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 951 | $17K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 582 | $15K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 301 | $15K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,058 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,738 | $10K |
| 87486 | <1% | 301 | $9K | |
| 87581 | <1% | 301 | $9K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 225 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 42 | $7K |
| 80305 | <1% | 817 | $6K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,210 | $5K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 514 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 119 | $2K |
| 81002 | <1% | 87 | $2K | |
| 83880 | <1% | 273 | $1K | |
| 81001 | <1% | 3,153 | $1K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,535 | $1K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 27 | $1K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,690 | $737.59 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 457 | $633.91 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 12 | $467.24 |
| 85379 | <1% | 58 | $438.83 | |
| 87040 | <1% | 35 | $408.60 | |
| 84439 | <1% | 46 | $395.71 | |
| 83690 | <1% | 1,533 | $270.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,280 | $206.28 |
| A9270 | Non-covered item or service | <1% | 7,367 | $187.88 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 16 | $166.62 |
| 80320 | <1% | 33 | $161.29 | |
| 86140 | <1% | 653 | $108.28 | |
| 80061 | Lipid panel | <1% | 15 | $60.36 |
| 85610 | <1% | 777 | $38.06 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 438 | $36.52 |
| 83735 | <1% | 320 | $35.82 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 157 | $15.54 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 348 | $12.74 |
| 85730 | 0% | 586 | $0.00 | |
| 71045 | Radiologic examination, chest; single view | 0% | 22 | $0.00 |
| 85651 | 0% | 184 | $0.00 | |
| 85027 | 0% | 462 | $0.00 | |
| 36000 | 0% | 32 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 41 | $0.00 |
| 84703 | 0% | 17 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 897 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARMS, ARLENE (CEO)
| Provider | Location | Paid |
|---|---|---|
| Valley Citizens' Foundation for Health Care INC | Monte Vista, CO | $130K |
| Valley Citizens' Foundation for Health Care INC | Monte Vista, CO | $39K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.